Skip to content
Search

Latest Stories

Government urged to act fast on PPE for pharmacies

The Royal Pharmaceutical Society (RPS) has called on the UK Government and devolved Parliaments to immediately provide personal protective equipment (PPE) across all settings, including pharmacies.

Public showing symptoms of COVID19 are still going into pharmacies and hospitals, RPS noted.


“Current PPE guidance assumes no one with COVID symptoms is coming to pharmacies or are on non-COVID hospital ward – this just isn’t the case. Guidance on PPE needs to change to reflect this real world situation,” Sandra Gidley, RPS president, said.

“There is no reason why some pharmacies in the UK have no PPE, whereas others already have access. Adequate stock of PPE must be supplied to pharmacies across the UK and to all other NHS settings.”

RPS has asked for urgent updates to guidance on PPE use, incorporating the circumstances pharmacists and their teams work.

“The Government and NHS have repeatedly tried to provide reassurance that adequate supplies of PPE are available to the pharmacy profession and that guidance is robust. This is not the reality experienced by our pharmacists across community, general practice and hospitals across the UK. This needs to change and change now,” Gidley said.

She warned that the virus could spread through pharmacies if adequate protective measures are not taken.

“Pharmacists are key workers in the battle against this pandemic and patients are depending on us more than ever. They must be safeguarded if their services are going to be able to continue to function. If they are not protected sufficiently, not only would they not be able to work, but they could spread the virus amongst their patients and other healthcare colleagues.

“No pharmacist in any setting should be left wondering what to do if the coughing patient in front of them has COVID.”

RPS has also requested pharmacists to follow national guidance on social distancing where possible.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less